Recent News

• 09.17.2025 - Atossa Therapeutics Appoints CORE IR for Investor Relations, Shareholder Communications and Public Relations Services
• 09.17.2025 - Atossa Therapeutics Appoints CORE IR for Investor Relations, Shareholder Communications and Public Relations Services
• 06.05.2025 - Albert G. Lowe, PhD
• 06.05.2025 - Albert G. Lowe, PhD
• 06.05.2025 - Jefferies Global Healthcare Conference
• 06.05.2025 - Jefferies Global Healthcare Conference
• 06.02.2025 - Atossa Therapeutics to Present at the Jefferies Global Healthcare Conference
• 06.02.2025 - Atossa Therapeutics to Present at the Jefferies Global Healthcare Conference

Recent Filings

• 09.08.2025 - 8-K Current report
• 09.08.2025 - EX-99.1 EX-99.1
• 08.21.2025 - 8-K Current report
• 08.12.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 08.12.2025 - EX-99.1 EX-99.1
• 08.12.2025 - 8-K Current report
• 07.29.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 07.16.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 05.22.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.16.2025 - 4 Statement of changes in beneficial ownership of securities